Health In Tech (HIT) Insider Grant: 27,000 Restricted Class A Shares to CFO
Rhea-AI Filing Summary
Health In Tech, Inc. (HIT) reporting person LinLin Qian, who serves as Chief Financial Officer, Director and a reported 10% owner, received a grant of 27,000 restricted shares of Class A Common Stock on 08/15/2025. The restricted shares were issued under the Health in Tech Equity Incentive Plan and vest based on operational milestones: 50% vest monthly over 12 months after the first specified program is launched and operational, and the remaining 50% vest monthly over 12 months after the second specified program is launched and operational. Following the transaction the reporting person beneficially owns 8,048,555 shares (which the filing states include 55,193 restricted shares and 7,993,362 Class A shares), while the filing excludes certain Class B shares and options.
Positive
- 27,000 restricted Class A shares granted to the CFO/Director, aligning pay with company operational milestones
- Vesting is milestone-based (two product launches), which ties value realization to execution rather than time-only vesting
- Reporting person retains significant ownership with 8,048,555 beneficially owned shares, indicating management stake
Negative
- None.
Insights
TL;DR: Insider CFO received milestone-based restricted stock, aligning executive incentives with product launches while modestly increasing reported ownership.
The grant of 27,000 restricted Class A shares ties management compensation to the operational launch of two specified programs, which strengthens alignment between executive incentives and company milestones. Vesting is milestone-linked rather than time-only, which may reduce gratuitous near-term dilution and focuses value delivery on execution. The reporting person remains a substantial holder with 8,048,555 beneficially owned shares, improving perceived management skin in the game. The filing excludes Class B shares and outstanding options, so total economic exposure is larger than Class A counts alone.
TL;DR: The transaction is a routine, non-cash equity grant that is execution-contingent and unlikely to materially affect near-term cap structure.
The 27,000-share award at $0 price indicates restricted shares issued as compensation rather than market purchases. Because vesting depends on successful launches, immediate dilution is limited to recorded outstanding shares; the filing shows 55,193 restricted shares included in beneficial ownership. Investors should note that additional instruments (2,700,000 Class B shares and 711,510 options) are excluded from the Class A total in this report, so full potential dilution requires reviewing other filings. Overall, this Form 4 documents governance-aligned compensation rather than capital-market activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 27,000 | $0.00 | -- |
Footnotes (1)
- Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace. Includes 55,193 shares of restricted stock and 7,993,362 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.
